D9652
Dialysis tubing cellulose membrane
avg. flat width 33 mm (1.3 in.)
Synonym(s):
Cellulose Dialysis Tubing, Cellulose Membrane, Dialysis Membrane
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NB.22
UNSPSC Code:
41123100
avg. diam.
21 mm , when full
avg. flat width
33 mm (1.3 in.)
capacity
~110 mL/ft
General description
Typical molecular weight cut-off = 14,000.
Packaging
Supplied in rolls, dry
Preparation Note
Removal of glycerol included as a humectant can be accomplished by washing the tubing in running water for 3-4 hours. Removal of sulfur compounds can be accomplished by treating the tubing with a 0.3% (w/v) solution of sodium sulfide at 80°C for 1 minute. Wash with hot water (60°C) for 2 minutes, followed by acidification with a 0.2% (v/v) solution of sulfuric acid, then rinse with hot water to remove the acid. This tubing will retain most proteins of molecular weight 12,000 or greater.
Analysis Note
May contain glycerin and sulfur compounds in more than trace amounts.
Still not finding the right product?
Explore all of our products under Dialysis tubing cellulose membrane
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
透析管
Dialysis Tubing
Margarida Miranda et al.
International journal of pharmaceutics, 572, 118695-118695 (2019-09-20)
The EMA draft guideline on quality and equivalence of topical products and the FDA non-binding product specific guidances release has encouraged the establishment of a regulatory background for in vitro release testing (IVRT). Herein, a novel framework applicable to the
Ahmet Alper Öztürk et al.
Combinatorial chemistry & high throughput screening, 23(10), 1064-1079 (2020-03-27)
To prepare lamivudine (LAM)-loaded-nanoparticles (NPs) that can be used in lung cancer treatment. To change the antiviral indication of LAM to anticancer. The development of anticancer drugs is a difficult process. One approach to accelerate the availability of drugs is
Ana Paula Dos Santos Matos et al.
Drug delivery and translational research, 10(6), 1552-1570 (2020-07-18)
Leishmaniasis is a neglected infectious disease caused by protozoan parasites from Leishmania genus species, affecting millions of people, in several countries. The current available treatment for cutaneous leishmaniasis (CL) has presented many side effects. In this way, micro- and nanotechnology
Global Trade Item Number
| SKU | GTIN |
|---|---|
| D9652-100FT | 04061835270040 |